ACHV ACHIEVE LIFE SCIENCES, INC.: institutional ownership and insider trading
123 funds reported holding $567M of ACHIEVE LIFE SCIENCES, INC. in their latest 13F filings; in Q2 2026 funds net bought $391M, with 46 new positions and 17 funds selling out; over the last 12 months insiders bought $0 and sold $175K on the open market.
ACHV revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$74.8M, EPS -0.80
- Quarter ended Mar 31, 2026: revenue n/a, net income −$10.2M, EPS -0.19
- Quarter ended Dec 31, 2025: revenue n/a, net income −$14.7M, EPS -0.23
- Quarter ended Sep 30, 2025: revenue n/a, net income −$14.4M, EPS -0.28
Famous investors holding ACHV
- Two Sigma (Two Sigma Investments): $2.88M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $2.13M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $1.16M, 0.0% of the portfolio
Largest institutional holders of ACHV
- Frazier Life Sciences Management, L.P. — $49.7M
- TPG GP A, LLC — $44.9M
- venBio Partners LLC — $38.6M
- Logos Global Management LP — $35.4M
- BlackRock, Inc. (BLK) — $34.4M
- FRANKLIN RESOURCES INC (BEN) — $32.3M
- Paradigm Biocapital Advisors LP — $32.3M
- VANGUARD CAPITAL MANAGEMENT LLC — $27.0M
- Propel Bio Management, LLC — $26.3M
- MARSHALL WACE, LLP — $24.6M
Recent ACHV insider trades
- Aug 19, 2026: Stewart Richard Alistair sold 20,626 shares ($175K)
- Sep 18, 2025: Stewart Richard Alistair sold 129,501 shares ($378K)
- Sep 18, 2025: Oki Mark K sold 50,060 shares ($146K)
- Sep 4, 2025: King Thomas Braxton sold 139,858 shares ($387K)
5%+ owners
- TPG GP A, LLC: 12.6% (Schedule 13D, filed Apr 24, 2026)
- venBio Global Strategic Fund V, L.P.: 10.0% (Schedule 13D, filed Apr 27, 2026)
- Logos Global Management LP: 10.0% (Schedule 13G, filed Aug 17, 2026)
- Paradigm BioCapital Advisors LP: 9.2% (Schedule 13G, filed Apr 24, 2026)
- Franklin Resources, Inc.: 8.3% (Schedule 13G/A, filed Jul 28, 2026)
- Frazier Life Sciences Public Fund, L.P.: 6.5% (Schedule 13G, filed Apr 24, 2026)